We use cookies for a better user experience. Read our Privacy Policy

I Agree

Soft Tissue Market

Soft Tissue Market (Product Type: Cartilage Allografts, Tendon Allografts, Meniscus, Ligament Allografts, Artificial Cornea, Dental Allografts, Collagen Allografts, and Amniotic Allografts; and End User: Hospitals, Orthopedic Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Optimized Manufacturing Protocols Being Considered by Stakeholders during COVID-19 Outbreak

The logistical considerations surrounding COVID-19 testing has become a part of the weekly routine for orthopedic surgeons. Although it is rare for patients to become COVID-19 positive, owing to scheduled osteochondral allograft (OCA) or the second stage of autologous chondrocyte implantation (ACI), it poses a problem when considering delivery of the expensive tissues. Mass vaccination drives are anticipated to reduce the burden of logistical and other regulatory restrictions.

Preventive measures, optimized manufacturing protocols, and post-graft release management options are growing popular in the soft tissue market. Stakeholders in the soft tissue market are increasing their communication between the surgical team and graft providers as a part of their optimized manufacturing protocols. Safe return of grafts, alternative options before wasting graft, and knowledge of liability for cost of grafts are being taken into consideration.

soft tissue market infographic

Request a sample to get extensive insights into the Soft Tissue Market

Companies Diverting Production Activities toward Artificial Scaffolds Due to Allograft Limitations

Allografts and xenografts are overcoming the limitations of autografts where the latter is subject to limited availability and donor-site morbidity. However, even allografts are prone to trigger immune rejection and disease transmission. Moreover, their osteoinductive potential is frequently impaired due to disruptive processing. Hence, companies in the soft tissue market are now increasing their research in alternative approaches with the help of artificial scaffolds that are specifically-designed to maintain physical integrity and promote bone ingrowth at the defect site.

Despite promising results in research for smart formulations to support improved control over growth factor release to bone regeneration sites, several of these ambitious materials are found to be limited only up to the animal study stage. As such, most of the activated devices that are being commercialized in clinics are based in allografts or collagen/tricalcium phosphate scaffolds. This is evident since collagen allografts are predicted to dominate the highest revenue share among all product types in the market during the assessment period.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Digital Technologies Augmenting Adoption of Custom 3D Bone Allografts

The soft tissue market is expected to reach US$ 8.6 Bn by 2031. The custom 3D bone allograft block fabrication is a fast growing phenomenon in the market, as the digital technology has drastically improved all areas of modern medicine and will continue to do so in the upcoming decade. Growing demand for accurate treatment planning, decline in patient chair-side time, and greater surgical accuracy have fueled the demand for custom 3D bone allografts in the modern implant dentistry. Companies in the soft tissue market are taking advantage of such developments to gain a strong research base in platelet-rich fibrin (PRF), which is being favored in regenerative dentistry.

Bone & BTB Tendon Allografts Help Deliver Ligament Reconstructions

Tendon allografts hold promising potentials in ligament reconstruction procedures. Companies in the soft tissue market are increasing their production capacities in tendon allografts, since they simplify the surgical technique by negating the need to harvest autograft, whilst eliminating issues associated with donor site morbidity. Allograft tissue specialists, Hospital Innovations, are building their product portfolio in bone & BTB (bone–patellar tendon–bone) tendon allografts that help to accommodate multiple techniques and fixation options in primary & revision ligament reconstructions.

Manufacturers in the soft tissue market are also innovating in non-bone tendon allografts that are an excellent alternative to autograft for any ligament reconstruction procedure. High quality non-bone tendon allografts have the ability to accurately size match and allows the surgeon with flexibility to perform a variety of surgical techniques.

Dehydrated Amniotic Membrane Sheets Pose Benefits in Regenerative Medicine

Apart from tendon and collagen allografts, companies in the soft tissue market are innovating in amniotic allografts. Surgenex® is gaining recognition as a producer and distributor of the highest quality of amniotic membrane tissue allograft in the healthcare industry. Manufacturers are taking cues from such innovations to increase the availability of amniotic allografts that are lightweight and flexible. This helps to provide a protective covering, offer ease of use, and reduce bulk at the site.

Unparalleled quality standards and serological testing are helping manufacturers in the soft tissue market to gain the FDA approval for products. Manufacturers are adopting processes that extract the membrane from the placental tissue, leaving only the amniotic membrane layer, which is dehydrated into a sheet-like product. Immunological properties in amniotic membranes help to offer benefits in regenerative medicine.

Regenerative Biomimetic Grafts Useful for Osteochondral Lesions in Outpatient Settings

Osteochondral lesions are a tear or a fracture that involve damage to both the cartilage and underlying bone. Locate Bio - an orthobiologics-focused regenerative medicine company, has received the Breakthrough Device Designation from the U.S. FDA (Food and Drug Administration) for its biomimetic graft Chondro3 meant for osteochondral lesions.

The increasing number of knee arthroscopies performed in the U.S. each year involves a chondral lesion, which is translating into revenue opportunities for manufacturers in the global soft tissue market. Regenerative biomimetic grafts are being designed to address this growing unmet clinical need. Proprietary designs involving three-layered collagen-based biodegradable matrix that can be delivered in a single procedure are being preferred by clinicians. Manufacturers are increasing the availability of affordable biomimetic grafts that can be useful in outpatient settings.

Increase in Production of New Cellular, Tissue Allografts for Healing of Burns

Companies in the soft tissue market are bolstering their output capabilities in innovative cellular and tissue allografts to help surgeons heal their patients. AlloSource® - an allografts provider in the U.S. has announced that it is naming its new cellular and tissue allografts under the new brand AlloConnex™.

Tendon and ligament transplantation is being carried out through skilled hands of surgeons. Manufacturers in the soft tissue market are building their portfolio in tendon and ligament allografts to support a multitude of procedures that surgeons perform to connect patients back to their active lifestyles. They are increasing the availability of single strand, double strand double bundle, and pre-shaped configurations in tendon and ligament allografts that help to heal severe burns.

soft tissue market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Soft Tissue Market

Analysts’ Viewpoint

The optimization of the logistical aspects of autologous cultured chondrocytes on porcine collagen membrane (MACI) and osteochondral allograft (OCA) surgery is becoming paramount amid the COVID-19 outbreak to avoid graft wastage. Implant surgeons are adopting custom printing 3D surgical guides in-office, following a plethora of growing courses available on the topic. The soft tissue market is slated to clock a favorable CAGR of ~7% during the forecast period. However, raw materials for tissue grafts require extensive screening to reduce the risk of disease transmission. Thus, to achieve this, stakeholders should process materials under strict cGMP (Current Good Manufacturing Practice) or ISO standards to ensure the safety, reproducibility, and scalability of the process.

Soft Tissue Market: Overview

  • Soft tissue connects, surrounds, or supports internal organs and bones, and includes muscle, tendons, ligaments, fat, fibrous tissue, lymph & blood vessels, fasciae, and synovial membranes
  • Soft tissue allografts are substitute tissues used for reconstruction of deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. Soft tissue is also used for wound care, dental surgery, aesthetics, etc.
  • Increase in clinical application in medical procedures & sports injuries and rise in prevalence of degenerative joint diseases are projected to drive the global soft tissue market
  • Clinical application of soft tissue in medical procedures and sports injuries is gradually increasing across the globe. Diabetic foot ulcer is a leading cause for hospitalization and is associated with significant morbidity and mortality. According to a report by the Transplant Department of Cleveland Clinic, nearly 30,000 surgeries with allograft tissue are performed every year in Cleveland Clinic, including meniscal transplants and anterior cruciate ligament procedures.
  • Rise in prevalence of degenerative joint diseases is projected to drive the demand for soft tissue products. According to World Health Organization statistics, degenerative joint diseases affect 9.6% men and 18% women aged over 60 having symptomatic osteoarthritis.

Market Segmentation: Soft Tissue Market

  • In terms of product type, the global soft tissue market has been classified into cartilage allografts, tendon allografts, meniscus, ligament allografts, artificial cornea, dental allografts, collagen allografts, and amniotic allografts. The tendon allografts segment has been split into Achilles tendon, patellar tendon, and others. The ligament allografts segment has been bifurcated into anterior cruciate ligament and medial collateral ligament.
  • Based on end user, the global soft tissue market has been divided into hospitals, orthopedic clinics, and others
  • Each of the segments has been analyzed in detail for soft tissue trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The soft tissue market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Regional Overview: Soft Tissue Market

  • In terms of region, the global soft tissue market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
  • North America accounted for the largest share of the global soft tissue market in 2020 and the trend is projected to continue during the forecast period. Growth of the soft tissue market in North America can be primarily ascribed to presence of major players, significant healthcare expenditure, early availability of new techniques, and increase in research activities across the country.
  • Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the soft tissue market in the region.
  • The current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2017 to 2031 along with CAGRs for the period from 2021 to 2031
  • The study also offers a list of recommendations, highlights, and useful insights of the market, which are estimated to help new companies willing to enter the market and existing companies to increase market share and in the decision-making process

Major Players

  • The report concludes with the company profiles section that includes key information about the major players in the global soft tissue market
  • Leading players analyzed in the report are
    • Corneat Vision
    • LinkoCare Life Sciences AB
    • Presbia plc
    • Bone Bank Allografts
    • MTF Biologics
    • CONMED Corporation
    • AlloSource
    • Arthrex, Inc.
    • Zimmer Biomet Holdings, Inc.
    • RTI Surgical, Inc.
  • Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments

Soft Tissue Market – Segmentation

TMR’s study on the global soft tissue market includes information divided into three segments: product type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global soft tissue market are discussed in detail.

Product Type
  • Cartilage Allografts
  • Tendon Allografts
    • Achilles Tendon
    • Patellar Tendon
    • Others
  • Meniscus
  • Ligament Allografts
    • Anterior Cruciate Ligament
    • Medial Collateral Ligament
  • Artificial Cornea
  • Dental Allografts
  • Collagen Allografts
  • Amniotic Allografts
End User
  • Hospitals
  • Orthopedic Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Soft Tissue Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of soft tissue market?

The global soft tissue market was worth US$ 4.3 Mn and is projected to reach a value of US$ 8.59 Bn by the end of 2031

What is the anticipated CAGR of the soft tissue market in the forecast period?

Soft tissue market is anticipated to grow at a CAGR of 7% during the forecast period

Which region is expected to project the highest market share in the soft tissue market?

North America accounted for a major share of the global soft tissue market

What are the key driving factors for the growth of soft tissue market?

The global soft tissue market is driven by better quality alternatives to autografts and technological advancements

Who are the key players in the global soft tissue market?

Key players in the global soft tissue market include Corneat Vision, LinkoCare Life Sciences AB, Presbia plc, Bone Bank Allografts, MTF Biologics, CONMED Corporation, AlloSource, Arthrex, Inc., Zimmer Biomet Holdings, Inc., and RTI Surgical, Inc.

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

4. Market Overview

    4.1. Introduction

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

    4.3. Global Soft Tissue Market Forecast

    4.4. Global Soft Tissue Market Outlook

5. Market Outlook

    5.1. Key Industry Events

    5.2. Product Pricing Analysis, by Region

    5.3. Impact of COVID-19 Pandemic

6. Global Soft Tissue Market Analysis, by Product Type

    6.1. Introduction

    6.2. Global Soft Tissue Market Value Share Analysis, by Product Type

    6.3. Global Soft Tissue Market Forecast, by Product Type

        6.3.1. Cartilage Allografts

        6.3.2. Tendon Allografts

            6.3.2.1. Achilles Tendon

            6.3.2.2. Patellar Tendon

            6.3.2.3. Others

        6.3.3. Meniscus

        6.3.4. Ligament Allografts

            6.3.4.1. Anterior Cruciate Ligament

            6.3.4.2. Medial Collateral ligament

        6.3.5. Artificial Cornea

        6.3.6. Dental Allografts

        6.3.7. Collagen Allografts

        6.3.8. Amniotic Allografts

    6.4. Global Soft Tissue Market Analysis, by Product Type

    6.5. Global Soft Tissue Market Attractiveness Analysis, by Product Type

7. Global Soft Tissue Market Analysis, by End-user

    7.1. Introduction

    7.2. Global Soft Tissue Market Value Share Analysis, by End-user

    7.3. Global Soft Tissue Market Forecast, by End-user

        7.3.1. Hospitals

        7.3.2. Orthopedic Clinics

        7.3.3. Others

    7.4. Global Soft Tissue Market Analysis, by End-user

    7.5. Global Soft Tissue Market Attractiveness Analysis, by End-user

8. Global Soft Tissue Market Analysis, by Region

9. Global Soft Tissue Market Analysis, by Region

    9.1. Global Soft Tissue Market Value Share Analysis, by Region

    9.2. Global Soft Tissue Market Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

10. North America Soft Tissue Market Analysis

    10.1. North America Soft Tissue Market Overview

    10.2. North America Soft Tissue Market Value Share and Attractiveness Analysis, by Country

    10.3. North America Soft Tissue Market Forecast, by Country

        10.3.1. U.S.

        10.3.2. Canada

    10.4. North America Soft Tissue Market Value Share and Attractiveness Analysis, by Product Type

    10.5. North America Soft Tissue Market Forecast, by Product Type

        10.5.1. Cartilage Allografts

        10.5.2. Tendon Allografts

            10.5.2.1. Achilles Tendon

            10.5.2.2. Patellar Tendon

            10.5.2.3. Others

        10.5.3. Meniscus

        10.5.4. Ligament Allografts

            10.5.4.1. Anterior Cruciate Ligament

            10.5.4.2. Medial Collateral ligament

        10.5.5. Artificial Cornea

        10.5.6. Dental Allografts

        10.5.7. Collagen Allografts

        10.5.8. Amniotic Allografts

    10.6. North America Soft Tissue Market Value Share and Attractiveness Analysis, by End-user

    10.7. North America Soft Tissue Market Forecast, by End-user

        10.7.1. Hospitals

        10.7.2. Orthopedic Clinics

        10.7.3. Others

11. Europe Soft Tissue Market Analysis

    11.1. Europe Soft Tissue Market Overview

    11.2. Europe Soft Tissue Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.3. Europe Soft Tissue Market Forecast, by Country/Sub-region

        11.3.1. Germany

        11.3.2. France

        11.3.3. U.K.

        11.3.4. Italy

        11.3.5. Spain

        11.3.6. Rest of Europe

    11.4. Europe Soft Tissue Market Value Share and Attractiveness Analysis, by Product Type

    11.5. Europe Soft Tissue Market Forecast, by Product Type

        11.5.1. Cartilage Allografts

        11.5.2. Tendon Allografts

        11.5.3. Achilles Tendon

            11.5.3.1. Patellar Tendon

            11.5.3.2. Others

            11.5.3.3. Meniscus

        11.5.4. Ligament Allografts

            11.5.4.1. Anterior Cruciate Ligament

            11.5.4.2. Medial Collateral ligament

        11.5.5. Artificial Cornea

        11.5.6. Dental Allografts

        11.5.7. Collagen Allografts

        11.5.8. Amniotic Allografts

    11.6. Europe Soft Tissue Market Value Share and Attractiveness Analysis, by End-user

    11.7. Europe Soft Tissue Market Forecast, by End-user

        11.7.1. Hospitals

        11.7.2. Orthopedic Clinics

        11.7.3. Others

12. Asia Pacific Soft Tissue Market Analysis

    12.1. Asia Pacific Soft Tissue Market Overview

    12.2. Asia Pacific Soft Tissue Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.3. Asia Pacific Soft Tissue Market Forecast, by Country/Sub-region

        12.3.1. China

        12.3.2. Japan

        12.3.3. India

        12.3.4. Australia & New Zealand

        12.3.5. Rest of Asia Pacific

    12.4. Asia Pacific Soft Tissue Market Value Share and Attractiveness Analysis, by Product Type

    12.5. Asia Pacific Soft Tissue Market Forecast, by Product Type

        12.5.1. Cartilage Allografts

        12.5.2. Tendon Allografts

            12.5.2.1. Achilles Tendon

            12.5.2.2. Patellar Tendon

            12.5.2.3. Others

        12.5.3. Meniscus

        12.5.4. Ligament Allografts

            12.5.4.1. Anterior Cruciate Ligament

            12.5.4.2. Medial Collateral Ligament

        12.5.5. Artificial Cornea

        12.5.6. Dental Allografts

        12.5.7. Collagen Allografts

        12.5.8. Amniotic Allografts

    12.6. Asia Pacific Soft Tissue Market Value Share and Attractiveness Analysis, by End-user

    12.7. Asia Pacific Soft Tissue Market Forecast, by End-user

        12.7.1. Hospitals

        12.7.2. Orthopedic Clinics

        12.7.3. Others

13. Latin America Soft Tissue Market Analysis

    13.1. Latin America Soft Tissue Market Overview

    13.2. Latin America Soft Tissue Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.3. Latin America Soft Tissue Market Forecast, by Country/Sub-region

        13.3.1. Brazil

        13.3.2. Mexico

        13.3.3. Rest of Latin America

    13.4. Latin America Soft Tissue Market Value Share and Attractiveness Analysis, by Product Type

    13.5. Latin America Soft Tissue Market Forecast, by Product Type

        13.5.1. Cartilage Allografts

        13.5.2. Tendon Allografts

            13.5.2.1. Achilles Tendon

            13.5.2.2. Patellar Tendon

            13.5.2.3. Others

        13.5.3. Meniscus

        13.5.4. Ligament Allografts

            13.5.4.1. Anterior Cruciate Ligament

            13.5.4.2. Medial Collateral Ligament

        13.5.5. Artificial Cornea

        13.5.6. Dental Allografts

        13.5.7. Collagen Allografts

        13.5.8. Amniotic Allografts

    13.6. Latin America Soft Tissue Market Value Share and Attractiveness Analysis, by End-user

    13.7. Latin America Soft Tissue Market Forecast, by End-user

        13.7.1. Hospitals

        13.7.2. Orthopedic Clinics

        13.7.3. Others

14. Middle East & Africa Soft Tissue Market Analysis

    14.1. Middle East & Africa Soft Tissue Market Overview

    14.2. Middle East & Africa Soft Tissue Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.3. Middle East & Africa Soft Tissue Market Forecast, by Country/Sub-region

        14.3.1. South Africa

        14.3.2. GCC countries

        14.3.3. Rest of Middle East & Africa

    14.4. Middle East & Africa Soft Tissue Market Value Share and Attractiveness Analysis, by Product Type

    14.5. Middle East & Africa Soft Tissue Market Forecast, by Product Type

        14.5.1. Cartilage Allografts

        14.5.2. Tendon Allografts

            14.5.2.1. Achilles Tendon

            14.5.2.2. Patellar Tendon

            14.5.2.3. Others

        14.5.3. Meniscus

        14.5.4. Ligament Allografts

            14.5.4.1. Anterior Cruciate Ligament

            14.5.4.2. Medial Collateral Ligament

        14.5.5. Artificial Cornea

        14.5.6. Dental Allografts

        14.5.7. Collagen Allografts

        14.5.8. Amniotic Allografts

    14.6. Middle East & Africa Soft Tissue Market Value Share and Attractiveness Analysis, by End-user

    14.7. Middle East & Africa Soft Tissue Market Forecast, by End-user

        14.7.1. Hospitals

        14.7.2. Orthopedic Clinics

        14.7.3. Others

15. Competition Landscape

    15.1. Competition Matrix

    15.2. Company Profiles

        15.2.1. Corneat Vision

            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.1.2. Product Portfolio

            15.2.1.3. SWOT Analysis

            15.2.1.4. Strategic Overview

        15.2.2. LinkoCare Life Sciences AB.

            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.2.2. Product Portfolio

            15.2.2.3. SWOT Analysis

            15.2.2.4. Strategic Overview

        15.2.3. Presbia plc

            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.3.2. Product Portfolio

            15.2.3.3. SWOT Analysis

            15.2.3.4. Strategic Overview

        15.2.4. Bone Bank Allografts

            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.4.2. Product Portfolio

            15.2.4.3. SWOT Analysis

            15.2.4.4. Strategic Overview

        15.2.5. MTF Biologics

            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.5.2. Product Portfolio

            15.2.5.3. SWOT Analysis

            15.2.5.4. Strategic Overview

        15.2.6. CONMED Corporation

            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.6.2. Product Portfolio

            15.2.6.3. Financial Overview

            15.2.6.4. SWOT Analysis

            15.2.6.5. Strategic Overview

        15.2.7. AlloSource

            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.7.2. Product Portfolio

            15.2.7.3. SWOT Analysis

            15.2.7.4. Strategic Overview

        15.2.8. Arthrex, Inc.

            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.8.2. Product Portfolio

            15.2.8.3. SWOT Analysis

            15.2.8.4. Strategic Overview

        15.2.9. Zimmer Biomet Holdings, Inc.

            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.9.2. Product Portfolio

            15.2.9.3. Financial Overview

            15.2.9.4. SWOT Analysis

            15.2.9.5. Strategic Overview

        15.2.10. RTI Surgical, Inc.

            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.2.10.2. Product Portfolio

            15.2.10.3. Financial Overview

            15.2.10.4. SWOT Analysis

            15.2.10.5. Strategic Overview

List of Tables

Table 01: Pricing Analysis, by Cartilage Allografts

Table 02: Pricing Analysis, by Ligament Allografts

Table 03: Pricing Analysis, by Meniscus

Table 04: Pricing Analysis, by Tendon Allografts

Table 05: Pricing Analysis, by Artificial Cornea

Table 06: Global Soft Tissue Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 07: Global Soft tissue Market Value (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 08: Global Soft tissue Market Value (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 09: Global Soft Tissue Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Global Soft Tissue Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 11: North America Soft tissue Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 12: North America Soft tissue Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 13: North America Soft tissue Market Size (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 14: North America Soft tissue Market Size (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 15: North America Soft tissue Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Europe Soft tissue Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Europe Soft tissue Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 18: Europe Soft tissue Market Size (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 19: Europe Soft tissue Market Size (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 20: Europe Soft tissue Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Asia Pacific Soft tissue Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Asia Pacific Soft tissue Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 23: Asia Pacific Soft tissue Market Size (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 24: Asia Pacific Soft tissue Market Size (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 25: Asia Pacific Soft tissue Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Latin America Soft tissue Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Latin America Soft tissue Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 28: Latin America Soft tissue Market Size (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 29: Latin America Soft tissue Market Size (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 30: Latin America Soft tissue Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Soft Tissue Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Soft Tissue Market Size (US$ Mn) Forecast, by Product Type, 2017–2031

Table 33: Middle East & Africa Soft Tissue Market Size (US$ Mn) Forecast, by Ligament Allografts, 2017–2031

Table 34: Middle East & Africa Soft Tissue Market Size (US$ Mn) Forecast, by Tendon Allografts, 2017–2031

Table 35: Middle East & Africa Soft Tissue Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Soft Tissue Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Soft Tissue Market Value Share, by Product Type, 2020

Figure 03: Global Soft Tissue Market Value Share, by End-user, 2020

Figure 04: Global Soft Tissue Market Value Share, by Region, 2020

Figure 05: Global Soft Tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 06: Global Soft Tissue Market Value (US$ Mn), by Cartilage Allografts, 2017–2031

Figure 07: Global Soft Tissue Market Value (US$ Mn), by Tendon Allografts, 2017–2031

Figure 08: Global Soft Tissue Market Value (US$ Mn), by Meniscus, 2017–2031

Figure 09: Global Soft Tissue Market Value (US$ Mn), by Ligament Allografts, 2017–2031

Figure 10: Global Soft Tissue Market Value (US$ Mn), by Artificial Cornea, 2017–2031

Figure 11: Global Soft Tissue Market Value (US$ Mn), by Dental Allografts, 2017–2031

Figure 12: Global Soft Tissue Market Value (US$ Mn), by Artificial Cornea, 2017–2031

Figure 13: Global Soft Tissue Market Value (US$ Mn), by Amniotic Allografts, 2017–2031

Figure 14: Global Soft Tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 15: Global Soft Tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 16: Global Soft Tissue Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 17: Global Soft Tissue Market Value (US$ Mn), by Orthopedic Clinics, 2017–2031

Figure 18: Global Soft Tissue Market Value (US$ Mn), by Others, 2017–2031

Figure 19: Global Soft Tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 20: Global Soft Tissue Market Value Share Analysis, by Region, 2020 and 2031

Figure 21: Global Soft Tissue Market Attractiveness Analysis, by Region, 2021-2031

Figure 22: North America Soft tissue Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 23: North America Soft tissue Market Value Share (%), by Country, 2020 and 2031

Figure 24: North America Soft tissue Market Attractiveness Analysis, by Country, 2021–2031

Figure 25: North America Soft tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 26: North America Soft tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 27: North America Soft tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 28: North America Soft tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 29: Europe Soft tissue Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 30: Europe Soft tissue Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 31: Europe Soft tissue Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 32: Europe Soft tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 33: Europe Soft tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 34: Europe Soft tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 35: Europe Soft tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 36: Asia Pacific Soft tissue Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 37: Asia Pacific Soft tissue Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 38: Asia Pacific Soft tissue Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Asia Pacific Soft tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 40: Asia Pacific Soft tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 41: Asia Pacific Soft tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 42: Asia Pacific Soft tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Latin America Soft tissue Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Latin America Soft tissue Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 45: Latin America Soft tissue Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 46: Latin America Soft tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 47: Latin America Soft tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 48: Latin America Soft tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: Latin America Soft tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Middle East & Africa Soft Tissue Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Middle East & Africa Soft Tissue Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 52: Middle East & Africa Soft Tissue Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 53: Middle East & Africa Soft Tissue Market Value Share Analysis, by Product Type, 2020 and 2031

Figure 54: Middle East & Africa Soft Tissue Market Attractiveness Analysis, by Product Type, 2021–2031

Figure 55: Middle East & Africa Soft Tissue Market Value Share Analysis, by End-user, 2020 and 2031

Figure 56: Middle East & Africa Soft Tissue Market Attractiveness Analysis, by End-user, 2021–2031

Figure 57: CONMED Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 58: CONMED Corporation, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 59: CONMED Corporation, Breakdown of Net Sales (%), by Region, 2020

Figure 60: CONMED Corporation, Breakdown of Net Sales (%), by Business Segment, 2020

Figure 61: Zimmer Biomet Holdings, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 62: Zimmer Biomet Holdings, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020

Figure 63: Zimmer Biomet Holdings, Inc., Breakdown of Net Sales (%), by Region, 2020

Figure 64: Zimmer Biomet Holdings, Inc., Breakdown of Net Sales (%), by Product Category, 2020

Figure 65: RTI Surgical, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 66: RTI Surgical, Inc., R& D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

926

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved